Lina_S

About Lina Silva Salinas

This author has not yet filled in any details.
So far Lina Silva Salinas has created 413 blog entries.

Treatment strategies and survival outcomes in older women with breast cancer: A comparative study between the FOCUS cohort and Nottingham cohort

2021-07-29T22:37:51+02:00

Schuil H, Derks M, Liefers GJ, Portielje J, van de Velde C, Syed B, Green A, Ellis I, Cheung KL, Bastiaannet E. J Geriatr Oncol. 2018 May 18. pii: S1879-4068(17)30286-2. doi: 10.1016/j.jgo.2018.05.004. [Epub ahead of print]

Treatment strategies and survival outcomes in older women with breast cancer: A comparative study between the FOCUS cohort and Nottingham cohort2021-07-29T22:37:51+02:00

Patterns and predictors of emergency department visits among older patients after breast cancer surgery: A population-based cohort study

2021-07-29T22:37:51+02:00

Westley T, Syrowatka A, Henault D, Rho YS, Khazoom F, Chang SL, Tamblyn R, Mayo N, Meguerditchian AN. J Geriatr Oncol. 2018 May;9(3):204-213. doi: 10.1016/j.jgo.2017.10.003. Epub 2017 Nov 28.

Patterns and predictors of emergency department visits among older patients after breast cancer surgery: A population-based cohort study2021-07-29T22:37:51+02:00

What Every Oncologist Should Know About Geriatric Assessment for Older Patients With Cancer: Young International Society of Geriatric Oncology Position Paper

2021-07-29T22:37:52+02:00

Loh KP, Soto-Perez-de-Celis E, Hsu T, de Glas NA, Battisti NML, Baldini C, Rodrigues M, Lichtman SM, Wildiers H. J Oncol Pract. 2018 Feb;14(2):85-94. doi: 10.1200/JOP.2017.026435.

What Every Oncologist Should Know About Geriatric Assessment for Older Patients With Cancer: Young International Society of Geriatric Oncology Position Paper2021-07-29T22:37:52+02:00

Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group

2021-07-29T22:37:52+02:00

Wildiers H, Tryfonidis K, Dal Lago L, Vuylsteke P, Curigliano G, Waters S, Brouwers B, Altintas S, Touati N, Cardoso F, Brain E. Lancet Oncol. 2018 Mar;19(3):323-336. doi: 10.1016/S1470-2045(18)30083-4. Epub 2018 Feb 9.

Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group2021-07-29T22:37:52+02:00
Go to Top